Economic evaluation of the sFlt-1/PlGF ratio for the short-term prediction of preeclampsia in a Japanese cohort of the PROGNOSIS Asia study

Keyphrases

• Appropriate Management 16%
• Asia 100%
• Asian Women 16%
• Clinical Decisions 16%
• Cost Analysis 16%
• Cost Analysis Model 16%
• Cost Savings 16%
• Decision Basis 16%
• Diagnostic Procedures 33%
• Economic Evaluation 100%
• Economic Impact 16%
• Health Care Costs 16%
• High-risk Individuals 16%
• Hospitalization 33%
• Hospitalization Rate 16%
• Japan 16%
• Japanese Healthcare System 16%
• Japanese Population 100%
• Low Risk 16%
• Placental Growth Factor (PlGF) 100%
• Prediction of Preeclampsia 100%
• Preeclampsia 66%
• Pregnant Women 16%
• Ratio Test 66%
• Short-term Outcomes 16%
• Short-term Prediction 100%
• Test Characteristics 16%
• Tyrosine 100%
• Unnecessary Hospitalization 33%

Medicine and Dentistry

• Cost Benefit Analysis 33%
• Diagnosis 33%
• Health Care Cost 50%
• Placental Growth Factor 100%
• Pre-Eclampsia 100%

Biochemistry, Genetics and Molecular Biology

• Placental Growth Factor 100%
• Tyrosine 100%